[HTML] cell.comFull View

[HTML][HTML] Antiviral agents for the treatment of COVID-19: Progress and challenges

M Singh, E de Wit - Cell Reports Medicine, 2022 - cell.com
The COVID-19 pandemic has seen clinical development and use of antiviral therapies at an
unprecedented speed. Antiviral therapies have greatly improved the clinical outcome in …
被引用次数：44 相关文章
[HTML] nih.gov

[HTML][HTML] Antiviral agents for the treatment of COVID-19: Progress and challenges

M Singh, E de Wit - Cell Reports Medicine, 2022 - ncbi.nlm.nih.gov
The COVID-19 pandemic has seen clinical development and use of antiviral therapies at an
unprecedented speed. Antiviral therapies have greatly improved the clinical outcome in …

Antiviral agents for the treatment of COVID-19: Progress and challenges.

M Singh, E de Wit - Cell reports. Medicine, 2022 - europepmc.org
The COVID-19 pandemic has seen clinical development and use of antiviral therapies at an
unprecedented speed. Antiviral therapies have greatly improved the clinical outcome in …
[HTML] sciencedirect.com

[HTML][HTML] Antiviral agents for the treatment of COVID-19: Progress and challenges

M Singh, E de Wit - Cell Reports Medicine, 2022 - Elsevier
The COVID-19 pandemic has seen clinical development and use of antiviral therapies at an
unprecedented speed. Antiviral therapies have greatly improved the clinical outcome in …

Antiviral agents for the treatment of COVID-19: Progress and challenges

M Singh, E de Wit - Cell reports. Medicine, 2022 - pubmed.ncbi.nlm.nih.gov
The COVID-19 pandemic has seen clinical development and use of antiviral therapies at an
unprecedented speed. Antiviral therapies have greatly improved the clinical outcome in …